LYTIX BIOPHARMA ASA

Lytix Biopharma ASA: Grant of share options to management and key personnel

Oslo, Norway – 3 September 2026 – Lytix Biopharma ASA (the “Company”) announces that the Board of Directors has approved the grant of 1,076,600 share options under the Company’s long-term incentive program. The Board considers the grants an important part of the Company’s strategy to attract and re...